2.4 to 10 6 copies/mL and were lower than levels for Epstein-Barr virus but comparable to those for HHV-6. Detection of KSHV DNA in saliva was not associated with oral KS or decreased peripheral blood CD4 cell counts. KSHV DNA was not detected in semen. Resistance of KSHV DNA from saliva to DNase treatment was consistent with the presence of virions. These data suggest that KSHV can replicate in the oropharynx and that salivary contact could contribute to KSHV transmission.
A new herpesvirus, named Kaposi's sarcoma (KS) -associ-(80% -100%), followed by HIV-infected gay and bisexual men ated herpesvirus (KSHV) or human herpesvirus (HHV)-8, has
without KS (28% -30%) and patients of sexually transmitted been identified in KS tumor tissue from patients from all KS disease clinics (13%), with most studies measuring a lower risk groups. KSHV infection appears to be necessary for the rate (õ5%) among HIV-negative blood donors [5 -7, 12] . One development of KS [1 -4] . Many human immunodeficiency study found that the seroprevalence in the general adult populavirus (HIV) -infected persons appear to be infected with KSHV tion may be as high as 25% [13] , and further refinement of but do not have clinical KS [5 -7] .
serologic methods is needed. These epidemiologic and seroThe route(s) of KSHV transmission and acquisition are unlogic data are consistent with a sexual route of KSHV transmisknown, although epidemiologic and serologic data suggest that sion. sexual transmission may occur. The incidence of KS is higher KS also occurs in an endemic pattern among older persons among homosexual and bisexual men than among patients inin the Mediterranean region and in an aggressive infantile patfected with HIV by parenteral blood exposure [8] . Among tern in parts of Africa. Seroprevalence rates in Italy and parts gay and bisexual men, KS has been linked to sexual practices of Africa are higher than in the United States, regardless of the involving fecal-oral contact, a high number of sex partners, and test methodology [6, 7, 13] . Thus, it is possible that nonsexual a history of sexually transmitted diseases [9 -11] . Preliminary transmission of KSHV also occurs. serologic analyses suggest that in the United States, KSHV is Body fluids and sites potentially involved in KSHV transmisrelatively restricted to adult gay or bisexual men. Patients with sion have not been clearly identified. Studies of the prevalence KS have the highest serologically defined KSHV infection rates of KSHV in semen have yielded conflicting results, ranging from the ubiquitous presence of low levels of KSHV DNA in the semen of most HIV-infected and some HIV-seronegative persons [14, 15] to the absence of detectable KSHV DNA in 200 mL of 10 mM TRIS (pH 8.0). Ten microliters (5%) of the lymphotropic and have latent and lytic life cycles in B lympho-DNA was used for each PCR reaction, and semiquantitative results cytes [17, 19] . EBV undergoes lytic infection in oropharyngeal (see below) were adjusted accordingly. HHV-6 and human bepithelial cells; persistent salivary shedding of EBV is well globin primers, PCR conditions, assay sensitivity, and product documented, and contact with saliva is responsible for EBV detection and quantitation have been described [22, 23] .
transmission [20, 21] . Other HHVs, including cytomegalovirus, For KSHV-specific PCR, primer pairs were KS-1 and -2, ampliherpes simplex virus (HSV)-1, and probably HHV-6 and fying the KS330Bam 233 fragment of ORF 26 [1] , and primer pairs HHV-7, can also be transmitted in saliva. We hypothesized KS-A and -B (CGTCGGTCGTGTCGTGTGAT and GCATAAthat KSHV may also be capable of replication in the orophar-TGTCTTCCTTGTGG), amplifying a 225-bp sequence within ynx and, therefore, undertook a study of KSHV DNA levels ORF 25 [24] . For EBV-specific PCR, primers EBER1-A and -B in saliva from patients with or at risk for KS. The levels of (GTTTTGCTAGGGAGGAGACG and GACCGAAGACGGCAG-AAAGC) were used to amplify a 118-bp region of EBER1 [25] . serum antibodies to KSHV-containing cell lines, induced to For varicella-zoster virus (VZV)-specific PCR, primers VZV3782 lytic KSHV replication, and clinical and immunologic variables and VZV3960 (TCCGTTCTGGGTTCTGGTTGA and GCGCGGwere also measured to determine the relationships between GGTCGCCGTATACTT) were utilized to amplify a 199-bp region these factors and the shedding of KSHV DNA in saliva. We of ORF 62 [26] .
have begun characterization of the KSHV DNA in saliva by Each 100-mL PCR mixture contained 50 mM KCl, 1.5 mM assessment of its sensitivity to digestion with DNase. were identical except for annealing temperatures (50ЊC for KS-A Analysis of peripheral blood cell T cell subsets was performed by and -B, 54ЊC for EBV and VZV). the University of Washington Hematopathology Laboratory. HIV PCR product detection utilized liquid hybridization with 32 Pserology was done using EIA and immunoblot analysis. The single labeled probes. KSHV-specific PCR products were detected with HIV-seronegative patient with KS was confirmed to be HIV uninprobes KS-P [1] and KS-P2 (CAACCCGTGGGCTTCGCAGC), fected by use of both serologic assays and a peripheral blood specific for PCR amplimers generated by KS-1 and -2 and KS-A mononuclear cell (PBMC) polymerase chain reaction (PCR) assay and -B, respectively. EBV PCR product was detected with probe for HIV DNA (Amplicor; Roche, Nutley, NJ).
EBER1-P (CCACAGACACCGTCCTCACCACCCG). VZV PCR All patients underwent a detailed skin and mucous membrane product was detected with probe VZV3899 (ACCACCCGGGCCexamination and a standardized interview. Acid-citrate-dextrose-CTGTGTTCG). PCR products (7 mL) and probe (10 6 cpm) were anticoagulated blood, whole expectorated saliva, and 4-mm punch heated in 25 mL of 1.2 M NaCl, 100 mM each dNTP, and 44% biopsies of normal skin and KS lesions were obtained. Saliva, formamide at 97ЊC for 5 min. Ten microliters of cooled hybridizawhole semen, and plasma were frozen at 070ЊC until analysis. tion reactions were analyzed on 6% acrylamide gels, dried, and Selected patients had parotid saliva collected by use of small, autoradiographed. buccal collection cups (Quality Biological, Gaithersburg, MD) or To quantitate KSHV PCR assays, a standard was prepared by by daily saliva collection in clinic or at home (with storage at 4ЊC
cloning KS-1 and -2 PCR product into TA vector (Invitrogen, San for £5 days). Plasma was collected by centrifugation of acidDiego) and quantitated by ultraviolet absorption. Specimen DNA citrate-dextrose blood (400 g, 10 min). PBMC isolated by ficolland log 10 dilutions of standard DNA (10 4 -10 1 copies) were amplihypaque centrifugation using heparin-free wash solutions were frofied using the same PCR master mix. The intensity of the specimen zen (070ЊC) in 150 mL of PBS. Saliva was also collected from 8 band at the predicted molecular weight was visually compared to healthy HIV-seronegative adult volunteers, and stored salivary the standard curve. Specimens were rerun in log 10 dilutions (in 10 DNA from 16 healthy adults from a study of HHV-6 was also mM TRIS, pH 8.0) when initial samples contained ú10 4 DNA analyzed [22] . copies/mL. Results are expressed as KSHV DNA copies per milliSpecimen input into PCR reactions was normalized for celluliter of sample for plasma and saliva and per 10 6 cells for PBMC. larity or volume. For saliva, plasma, and semen, 200-to 400-mL For tissue, 2 1 10 6 b-globin DNA copies were assigned the value samples were submitted for DNA extraction. For PBMC, 3 1 10 6 of 1 1 10 6 cells. In preliminary experiments, PBMC number meacells were used. One-fifth to one-tenth of fresh skin biopsies were sured by hemocytometry and quantitative b-globin PCR were conused for DNA extraction. For formalin-fixed, paraffin-embedded cordant. EBV DNA was quantitated as described for KSHV. DNA tissue, 3-9 serial 10-to 20-mm sections were deparaffinized [23] from Raji cells containing an average of 50 EBV genomes/cell before DNA isolation.
[27] was used for the standard curve. Sensitivity of the KSHV, PCR analysis. DNA was isolated by phenol-chloroform ex-EBV, and VZV PCR reactions was routinely õ10 copies of viral traction after overnight digestion at 50ЊC with 100 mg/mL protein-DNA. ase K, 0.5% SDS, 25 mM EDTA, 100 mM NaCl, and 10 mM To ensure that negative results were not due to nonspecific TRIS (pH 8.0) [24] ; precipitated with sodium acetate (0.25 M), inhibition of PCR, we constructed an internal positive control, KSfly2, that would be amplified in PCR using KS-1 and -2 primers. glycogen (100 mg/mL), and 2 vol of ethanol; and resuspended in KS-fly2 DNA is identical to the KS330Bam 233 PCR product except to KSHV. All sera were negative for reactivity with the BJAB control B-cell line at a dilution of 1:40. that the KS-P probe sequence is replaced by a 21-bp Drosophila species DNA sequence [28] . Fifty copies of KS-fly2 DNA were Statistical methods. Comparison of detection of KSHV DNA between specimen sites was made with Fisher's exact test, twoincluded in each PCR reaction using KS-1 and -2 primers. Each KS-1 and -2 PCR product was hybridized with a 32 P-labeled probe tailed. Specimen sets from which 1 of the comparison specimens displayed inhibition of PCR or was not available were excluded. specific for the Drosophila species DNA sequence [28] , electrophoresed, and autoradiographed. DNA from specimens exhibiting
Comparison of peripheral lymphocyte numbers between groups was performed on log-transformed cell counts with the Manninhibition was repurified and reamplified. All negative KS-1 and -2 PCR results in this study required detection of KS-fly2 DNA. To Whitney U test, two-tailed. CD4 cell counts of 0 were assigned a value of 1 to permit log transformation. Comparison of titers of detect failure to isolate DNA, cellular specimens were analyzed by PCR for human b-globin [28] . To monitor false-positives, specanti-KSHV antibodies between groups was performed on logtransformed titers, using Mann-Whitney U test, two-tailed. Antiimen sets were processed in parallel (from DNA isolation through autoradiography) with aliquots of HSB2 cells [23] . PCR reactions KSHV titers and peripheral lymphocyte numbers were correlated after log transformation of both variables and exclusion of data without DNA were also included in each PCR run.
Saliva fractionation and assessment of viral DNA susceptibility pairs with negative anti-KSHV tests by linear regression; P values are two-tailed. Throughout, analysis was performed using Instat to DNase. Saliva (5 mL) was liquefied with 1 mM dithiothreitol for 10 min at room temperature, centrifuged (800 g) for 10 min, (Graphpad Software, San Diego). and filtered (0.8 mm). The cell-free salivary fluid was ultracentrifuged at 90,000 g for 60 min, and pelleted material was resuspended in 100 mL of one-third-strength PBS. DNA was extracted Results from the supernatant and pellet, and 5% was used for PCR with
Detection of KSHV DNA in saliva from patients with KS. (figure 2). These studies were done 20 -60 days after the initial EBV and HHV-6 DNA levels were also determined in patients 1 -3 and 8: All had detectable salivary HHV-6 DNA (20/21 specimen collection, and KSHV DNA was found in 3 of the 4 patients. In 2 subjects (patients 2 and 8), KSHV DNA was specimens), and 3 of the 4 patients had detectable salivary EBV DNA (16/16 specimens). The KSHV DNA levels for consistently present at high copy numbers (10 3 -10 6 copies/mL of saliva) in all samples. Patient 3, who had 10 4 copies/mL on patients 2 and 8 were comparable to levels of HHV-6 DNA and at least 10-to 100-fold lower than levels of EBV DNA. study entry, had low positive PCR detection on 2 of 5 days. [19] . The resistance of KSHV DNA to digestion by DNase KSHV DNA by PCR included lesion and normal skin tissue, was assessed in salivary material from 3 patients. KSHV DNA PBMC, plasma, and semen (table 1). Tissue samples of KS fractionated primarily into the pellet fraction of ultracentrifuged lesions from 22 of the 25 subjects were evaluated, and KSHV cell-free salivary fluid (Vieira J, et al., unpublished data). The DNA was detected in 19 (86%). KSHV DNA levels ranged KSHV DNA recovered from pelleted salivary fluid was resisfrom 10 3 to 10 6.6
/10 6 lesion cells as assessed by semiquantitatant to DNase (figure 3), as was endogenous EBV virion DNA tive KSHV and b-globin PCR performed on 9 specimens. The present in the saliva. VZV DNA fragments added prior to 3 negative specimens were paraffin-embedded tissue collected digestion were completely degraded. These data are consistent 7 years prior to analysis (patient 2) and 2 biopsies of skin lesions (patients 7 and 11). Of note, lesions had been clinically with the presence of KSHV virions in saliva. all, 22 (88%) of 25 patients with active or resolved KS were † Specimens for 10 subjects were tested.
seropositive for anti-KSHV antibodies (table 1) , including both subjects with resolved KS (patients 1 and 2) and the HIVnegative subject with KS (patient 10). The titers ranged up to 1:10,240 (patient 21), with an overall geometric mean titer of Detection of KSHV DNA in specimens from patients without KS. We also tested specimens from 20 HIV-infected homo-1:254 among the HIV-positive patients with KS and detectable anti-KSHV antibodies (n Å 21) (table 3). Geometric mean sexual or bisexual male patients without clinical KS (table 2) . Salivary KSHV DNA was detected in single specimens from titers of anti-KSHV antibodies within this group were 1:168 for patients with KSHV DNA in saliva (n Å 15), compared 3 (15%) of 20 patients, using KS-1 and -2 primer pairs, and was confirmed in each case with KS-A and -B primer pairs. with 1:718 for patients without KSHV DNA in saliva (n Å 6) (P Å .07, Mann-Whitney U test, two-tailed). There was no The levels of KSHV DNA were low in saliva specimens from this group (10 2.5 -10 3.5 DNA copies/mL). KSHV DNA was also correlation between log-transformed CD4 cell count and logtransformed titer of anti-KSHV antibodies within this same detected in PBMC from 2 of 20 patients. Positive saliva and PBMC specimens were from separate individuals, yielding a group (r Å .33, P Å .12). Among 20 HIV-positive, KS-negative men, 11 (55%) were prevalence of 25% (5 of 20) for KSHV infection among this population, as detected by PCR. KSHV DNA was not detected seropositive for anti-KSHV antibodies (table 3) , including all 5 men with KSHV DNA in saliva or PBMC. The overall geoin semen from a subgroup of 10 subjects, including 2 patients with KSHV DNA in saliva, 4 additional patients seropositive metric mean titer among KSHV-seropositive, KS-negative men with HIV (1:46) was significantly lower than the geometric for KSHV, and 4 patients seronegative for KSHV (see below). mean titer among KSHV-seropositive, KS-positive men with 6 DNA copies/mL) were detected in saliva specimens from patients positive throat swab. Sputum, expected to contain some saliva, was positive in only 1 of 27 patients with KS [19] . Our study with KS. Among 4 patients with KSHV DNA in saliva at their initial study visit, KSHV DNA shedding in saliva during a differed from these in several respects. We used a PCR assay with a documented sensitivity of 1-10 DNA copies. Moreover, daily sampling protocol was consistent in 2, intermittent in 1, and not detected in another. Thus, KSHV DNA shedding in as saliva can often inhibit PCR reactions to give false-negative results [22] , we assessed all specimens for inhibition of PCR. To saliva may be episodic in some patients. The KSHV DNA in saliva was resistant to DNase treatment, consistent with the reduce false-positive results, all initial positive KSHV PCR results were confirmed with a second KS-specific primer pair, and repeat presence of KSHV virions. We therefore hypothesize that salivary contact may be involved in some cases of KSHV transspecimen collections were obtained from 4 patients. The daily sampling data indicate that some persons display intermittent mission.
The source or sources of KSHV DNA in saliva are unknown. shedding of KSHV DNA in saliva; therefore, shedding may be missed if only single specimens are analyzed. After our analysis The shedding of KSHV DNA -positive tumor cells or debris into saliva may have contributed to the KSHV DNA detected was underway, results of PCR analysis of KSHV DNA in saliva from HIV-positive patients from Houston became available [33] . in some patients. However, among HIV-infected patients with KS, the prevalence and levels of salivary KSHV DNA were KSHV DNA was detected with nested PCR in 25 (32.9%) of 76 specimens. The HIV risk factors and clinical KS status of these similar between patients with and without oral KS lesions. KSHV DNA was also detected in saliva from patients with patients were not presented. We did not detect KSHV DNA in the saliva of 24 healthy resolved KS. Eleven of the 18 patients with KSHV DNA in saliva, including 4 with high levels of viral DNA ( §10 5.7 copadult donors. Our results are consistent with negative findings for 39 HIV-negative individuals [33] . If KSHV infection is ies/mL), did not have oral KS. Several such patients had prolonged (several years) follow-up periods between the diagnosis rare in healthy adults in the United States [5 -7] , our negative findings may simply reflect this fact. If, however, many apparof cutaneous KS and specimen collection, and none have developed clinically evident oral KS in 3 -9 months of follow-up ently healthy adults are infected with KSHV [13 -15, 32] , then these findings could indicate tight immunologic control of after specimen collection. Moreover, we detected KSHV DNA in saliva of HIV-infected patients without any evidence of KS KSHV replication in the saliva-accessible compartment among healthy persons. at enrollment or during subsequent follow-up. Thus, shedding of tumor cells into saliva appears not to be the only source of Increased viral shedding in the saliva of patients with compromised cellular immunity has been documented for HSV-1, KSHV DNA in saliva.
Replication of KSHV in normal oropharyngeal cells is an-HSV-2, and EBV. The possible roles of KSHV-specific cellular immune responses in control of KSHV infection and malignanother potential source of the KSHV DNA in saliva. KSHV is known to preferentially localize in B lymphocytes in the PBMC cies associated with KSHV remain unknown. We did not detect a correlation between CD4 cell counts and salivary shedding [17] and to be present in lymphoid tissue [32] . 
